BridgeMD
New treatment option for Bone Loss
Official title Minimally Invasive Sinus Lift Through the Interradicular Septum
ClinicalTrials.gov ID: NCT05237570
What this study is testing
- What it's testing
- This study aims to describe a new approach for the reconstruction of the alveolar process in the sinus area. This minimally invasive approach will access the maxillary sinus through the alveolar process, elevating the sinus membrane in the area immediately above it.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient older than 18 years.
- Plaque index and bleeding index less than 30%.
- Invagination of the sinus cavity in the interradicular area of the upper first molar.
- Upper first molar not restorable and with height of the interradicular remnant less than 5 mm.
You likely can't join if
- Presence of systemic disease contraindicating the intervention.
- Pregnant women.
The study team makes the final eligibility decision.
Where it's taking place
- Murcia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Murcia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.